Venmax Drugs & Pharmaceuticals Ltd Share Price Today - Venmax Drugs & Pharmaceuticals Ltd Stock Price Live NSE/BSE

Venmax Drugs & Pharmaceuticals Ltd

NSE: BSE: 531015

₹24.85

(-4.39%)

Fri, 27 Mar 2026, 07:40 pm

MTF 5xInvest in Venmax Drugs & Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap0

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Venmax Drugs & Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
23.25
Net Profit
-0.01
P/B
-22.63
Sector P/E
40.02
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
1.23
Interest Cover (Industry)
2.84
ROCE (Industry)
14.19
RONW (Industry)
15.11
ROE
0
ROCE
0
Debt/Equity
0.11
EPS (TTM)
0.99
Dividend Yield
0
Book Value
11.53
Interest Cover
0

Analysis

No Result Found

Financials

No Result Found

Ratios

No Result Found

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	15.14	23.14	23.14	23.14	23.14
FII	0	0	0	0	0
DII	0	0	0	0.15	0.15
Public	84.86	76.86	76.86	76.72	76.72
Government	0	0	0	0	0

Technical Analysis

RSI

52.79

MACD

0.01

50 DMA

25.54

200 DMA

26.41

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	41.54	33.76	29.58	25.98	21.80	18.20	10.42
Fibonacci	33.76	30.79	28.96	25.98	23.01	21.18	18.20
Camarilla	27.53	26.82	26.10	25.98	24.68	23.96	23.25

Pivots Level: Classic

+15.56

41.54

+7.78

33.76

+3.59

29.58

25.98

Pivot Point

LTP: 25.90

-4.19

21.80

-7.78

18.20

-15.56

10.42

Moving Average

SMAEMA

Period

Value

10-EMA
25.36
20-EMA
25.23
30-EMA
25.33
50-EMA
25.58
100-EMA
25.95
200-EMA
25.21

Announcement Date	Purpose	Action
07 Feb 2026	board-meetings	Quarterly Results
02 Sept 2025	agm
11 Jan 2025	egm
22 Aug 2024	agm
06 Sept 2023	agm
19 Sept 2022	agm

Peer Comparison

No Result Found

Venmax Drugs & Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd

Lupin Ltd

Venmax Drugs & Pharmaceuticals Ltd About

Venmax Drugs & Pharmaceuticals is engaged in the business of pharmaceutical products, drug intermediaries and API’s .

Industry

Trading

Founded

1988

Headquarters

CEO

Employees

Contact

Website

http://www.venmaxdrugs.com

venmaxdrugs@gmail.com

Phone

Location

Sy No 115 Brig Sayeed Road, Hanumanji Colony Old Bowenpall, Secunderabad, Telangana, 500009

Year	History
1995	Converted into a public limited company. Obtained a fresh Certificate of Incorporation from the Registrar of Companies, Andhra Pradesh.
2009	Changed its name from Yenkey Drugs and Pharmaceuticals Ltd. to Venmax Drugs & Pharmaceuticals Ltd. Registered Office of the Company has been shifted from Plot No. 1-B12, 2nd floor, S.V.Co-operative Industrial Estate, Balanagar, Hyderabad to 8-3-319/3, Behind Sarathi Studio, Yellareddyguda, Hyderabad.
2013	Registered office has been shifted from Plot No-35, Shivbagh Colony, Ameerpet, Hyderabad to H.NO 6-3-349/35, Flat No-21B, Dwaraka Avenue, DwarakaPuri Colony, Punjagutta, Hyderabad.
2023	Acquired Brownfield Hotel in Varanasi Uttar Pradesh and Aloft Bengaluru Whitefield Hotel in Karnataka.
2024	Launched Raaya by atmosphere in Maldives. Completed the acquisition transaction of Aloft ORR Bengaluru, Anantara Maldives and Conrad Maldives.

Client Name	Order Side	QTY	Avg Price	Date
SAMTA POLYMERS LTD	Buy	44820	17.51	04 Mar 2025
KAVITA PARIKH	Buy	30000	19.12	04 Mar 2025
SANJAY P PARIKH	Buy	30000	19.35	04 Mar 2025
MANASA REDDY DEVIREDDY	Buy	49998	17.51	04 Mar 2025
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Sell	45155	17.51	04 Mar 2025
GREEN PEAKS ENTERPRISES LLP	Buy	47656	30.88	04 Feb 2025
DEEPIKAJINDAL	Buy	26276	29.1	03 Feb 2025
RIGHT TIME CONSULTANCY SERVICE PRIVATE LIMITED	Sell	35000	30.28	03 Feb 2025
GREEN PEAKS ENTERPRISES LLP	Sell	59000	29.1	03 Feb 2025
SUDHANSHU KANDA	Buy	50000	30.28	03 Feb 2025

Venmax Drugs & Pharmaceuticals Ltd News

Venmax Drugs Allots 28 Lakh Equity Shares

Venmax Drugs and Pharmaceuticals converts 28,00,000 warrants into equity shares at Rs. 20 each, raising Rs. 4.20 crore from two non-promoter investors.

23 Mar 2026

companies

Venmax Drugs Elevates Venkata Rao to Managing Director

Venmax Drugs & Pharmaceuticals promotes Whole Time Director Venkata Rao Sadhanala to Managing Director for 5 years with Rs. 30 lakhs annual remuneration, subject to shareholder approval.

11 Mar 2026

stocks

Venmax Drugs Reports No Deviation in Fund Utilization

Venmax Drugs & Pharmaceuticals confirms no deviation in use of Rs. 20.05 crores raised through preferential issue for Q3 FY26, with Rs. 3.98 crores utilized till December 31, 2025.

07 Feb 2026

stocks

Venmax Drugs Allots 7.75 Lakh Equity Shares

Venmax Drugs and Pharmaceuticals converts warrants worth ₹1.16 crores, allotting 7,75,000 equity shares to three non-promoter investors at ₹20 per share on January 21, 2026.

21 Jan 2026

co actions results

Venmax Drugs Pharmaceuticals Independent Director Dakshita Jain Resigns

Dakshita Jain resigned as Non-Executive Independent Director of Venmax Drugs Pharmaceuticals Limited effective November 24, 2025, citing personal and professional commitments as reasons for her departure. The Board of Directors accepted her resignation during their meeting, with Jain confirming no material reasons exist beyond those stated in her resignation letter.

25 Nov 2025

corporate governance

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800